Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer

Fig. 1

The percentage of MDSCs in the peripheral blood of lung cancer patients is negatively correlated with the ratio of Th1/CTL cells. a-b The proportions of CD11b + CD33 + HLA-DR-CD14- MDSCs (n = 61), CD3 + CD8-IFN-γ + Th1 cells and CD3 + CD8 + IFN-γ + CTLs (n = 56) in the peripheral blood of lung cancer patients and healthy donors were detected by flow cytometry (FCM). c The correlation between the proportion of Th1/CTL cells and the percentage of MDSCs in the peripheral blood of lung cancer patients. ***P < 0.001, **P < 0.01, ns = no significance

Back to article page